Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Go back to Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights| (NASDAQ: DFTX) | Delayed: 38.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.09 | 52 Week High | $ | |||
| Open | $38.09 | 52 Week Low | $ | |||
| Day High | $38.09 | P/E | N/A | |||
| Day Low | $38.09 | EPS | $ | |||
| Volume | 10,294 | |||||

